<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Sharma V</submitter><funding>Department of Science and Technology, Chandigarh Administration, India</funding><pagination>1710</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12474774</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>16(1)</volume><pubmed_abstract>&lt;h4>Aim&lt;/h4>Pancreatic cancer (PC) is marked by high mortality and resistance to conventional therapies, largely due to a dense desmoplastic stroma that promotes drug resistance and metastasis. This highlights the need for specific non-invasive diagnostic markers. MicroRNAs (miRNAs), known for regulating gene expression and influencing tumor behavior, have emerged as promising biomarkers. This study aimed to evaluate the expression of circulating miR-6875 and miR-1307 in PC patients to explore their diagnostic potential.&lt;h4>Methods&lt;/h4>Blood, urine, and saliva samples were collected from 20 PC patients and 12 healthy controls. RNA extraction and cDNA synthesis were performed following standard protocols, and quantitative real-time PCR assays were used to quantify miR-6875 and miR-1307 expr</pubmed_abstract><journal>Discover oncology</journal><pubmed_title>Potential of circulating miR-6875 and miR-1307 as non-invasive diagnostic biomarkers for pancreatic cancer.</pubmed_title><pmcid>PMC12474774</pmcid><funding_grant_id>S&amp;T&amp;RE/RP/147/E-2873/(22-23)/SANC/09/2022/907-915</funding_grant_id><pubmed_authors>Arora A</pubmed_authors><pubmed_authors>Gupta R</pubmed_authors><pubmed_authors>Singh H</pubmed_authors><pubmed_authors>Bansal S</pubmed_authors><pubmed_authors>Lohani S</pubmed_authors><pubmed_authors>Aggarwal A</pubmed_authors><pubmed_authors>Sharma V</pubmed_authors><pubmed_authors>Semwal A</pubmed_authors><pubmed_authors>Sharma M</pubmed_authors></additional><is_claimable>false</is_claimable><name>Potential of circulating miR-6875 and miR-1307 as non-invasive diagnostic biomarkers for pancreatic cancer.</name><description>&lt;h4>Aim&lt;/h4>Pancreatic cancer (PC) is marked by high mortality and resistance to conventional therapies, largely due to a dense desmoplastic stroma that promotes drug resistance and metastasis. This highlights the need for specific non-invasive diagnostic markers. MicroRNAs (miRNAs), known for regulating gene expression and influencing tumor behavior, have emerged as promising biomarkers. This study aimed to evaluate the expression of circulating miR-6875 and miR-1307 in PC patients to explore their diagnostic potential.&lt;h4>Methods&lt;/h4>Blood, urine, and saliva samples were collected from 20 PC patients and 12 healthy controls. RNA extraction and cDNA synthesis were performed following standard protocols, and quantitative real-time PCR assays were used to quantify miR-6875 and miR-1307 expr</description><dates><release>2025-01-01T00:00:00Z</release><publication>2025 Sep</publication><modification>2026-06-03T21:43:32.915Z</modification><creation>2026-05-02T03:08:00.684Z</creation></dates><accession>S-EPMC12474774</accession><cross_references><pubmed>41003822</pubmed><doi>10.1007/s12672-025-03490-3</doi></cross_references></HashMap>